Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Sponsor: AbbVie
Summary
This study will assess the long-term safety of oral Eluxadoline administered to pediatric participants with IBS-D who have completed study intervention in the Phase 2 study 3030-202-002 or the Phase 3 study 3030-303-002.
Official title: A Phase 3, Long-term Safety Study of Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Key Details
Gender
All
Age Range
6 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
124
Start Date
2021-08-13
Completion Date
2032-12
Last Updated
2025-07-17
Healthy Volunteers
No
Conditions
Interventions
25mg Eluxadoline
Oral Tablets
100mg Eluxadoline
Oral Tablets
Locations (6)
Kindred Medical Institute, LLC /ID# 227595
Corona, California, United States
Valencia Medical & Research Center /ID# 246221
Miami, Florida, United States
Florida Research Center, Inc. /ID# 227597
Miami, Florida, United States
Sleep Care Research Institute d/b/a Clinical Research Institute /ID# 227600
Stockbridge, Georgia, United States
IPS Research Company /ID# 227594
Oklahoma City, Oklahoma, United States
Preferred Primary Care Physicians, Inc. /ID# 227596
Pittsburgh, Pennsylvania, United States